Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp484 | Other diseases of bone and mineral metabolism | ECTS2013

Osteocyte metabolism on post-menopausal bone loss and role of hormone replacement therapy

Silva Ana Maria , Moreira Ana Carolina , Santos Maria Sancha , Albuquerque Anabela , Ferreira Izilda , Gil Paulo , Isidoro Jorge , Videira Romeu , Carvalho Rui , Sardao Vilma

Introduction: Osteocytes play a major role in the bone remodelling unit (BRU). Thus, we hypothesize that mitochondrial bioenergetics impairment and mitochondrial/peroxisomal fatty acid β-oxidation unbalance is a cause of osteocytes metabolic decline during 17β-estradiol (E2) reduction. E2 and a phytochemical substitute, coumestrol (COU) were used (30 mg/kg during 24 h in ovariectomized rats in order to compare bone loss with sham-operated animal...